Screener
Taysha Gene Therapies, Inc. TSHA Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344610
FAQ
- What is Taysha Gene Therapies, Inc.'s prepaid & other current?
- Taysha Gene Therapies, Inc. (TSHA) reported prepaid & other current of $6.03M in Q2 2026.
- How has Taysha Gene Therapies, Inc.'s prepaid & other current changed year-over-year?
- Taysha Gene Therapies, Inc.'s prepaid & other current increased by 97.3% year-over-year, from $3.05M to $6.03M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s prepaid & other current?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s prepaid & other current has grown at a -23.9% compound annual growth rate (CAGR), from $39.63M to $13.31M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Taysha Gene Therapies, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude